[
1. Adhikari NKJ, Fowler RA, Bhagwanjee S, Rubenfeld GD. Critical care and the global burden of critical illness in adults. Lancet. 2010 Oct 16;376(9749):1339-46. DOI: 10.1016/S0140-6736(10)60446-110.1016/S0140-6736(10)60446-1
]Search in Google Scholar
[
2. Fleischmann C, Scherag A, Adhikari NKJ, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72. DOI: 10.1164/ rccm.201504-0781OC10.1164/rccm.201504-0781OC
]Search in Google Scholar
[
3. Minasyan H. Sepsis and septic shock: Pathogenesis and treatment perspectives. J Crit Care. 2017 Aug;40:229-42. DOI: 10.1016/j.jcrc.2017.04.01510.1016/j.jcrc.2017.04.015
]Search in Google Scholar
[
4. Sherwin R, Winters ME, Vilke GM, Wardi G. Does Early and Appropriate Antibiotic Administration Improve Mortality in Emergency Department Patients with Severe Sepsis or Septic Shock? J Emerg Med. 2017 Oct;53(4):588-95. DOI: 10.1016/j. jemermed.2016.12.00910.1016/j.jemermed.2016.12.009
]Search in Google Scholar
[
5. Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. JAMA. 2017 Oct 3;318(13):1241-9. DOI: 10.1001/jama.2017.1383610.1001/jama.2017.13836
]Search in Google Scholar
[
6. Giannakopoulos K, Hoffmann U, Ansari U, Bertsch T, Borggrefe M, Akin I, et al. The Use of Biomarkers in Sepsis: A Systematic Review. Curr Pharm Biotechnol. 2017;18(6):499-507. DOI: 10.2174/138920101866617 060108011110.2174/1389201018666170601080111
]Search in Google Scholar
[
7. Kovacs J, Gurzu S, Jung J, Szederjesi J, Copotoiu S-M, Copotoiu R, et al. Clinico-pathological particularities of the shock-related pancreatitis. Pathol Oncol Res. 2012 Oct;18(4):977-81. DOI: 10.1007/s12253-012-9528-610.1007/s12253-012-9528-6
]Search in Google Scholar
[
8. Gauer R, Forbes D, Boyer N. Sepsis: Diagnosis and Management. AFP. 2020 Apr 1;101(7):409-18.
]Search in Google Scholar
[
9. Matthaiou DK, Ntani G, Kontogiorgi M, Poulakou G, Armaganidis A, Dimopoulos G. An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Med. 2012 Jun;38(6):940-9. DOI: 10.1007/s00134-012-2563-710.1007/s00134-012-2563-7
]Search in Google Scholar
[
10. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013 May;13(5):426-35. DOI: 10.1016/S1473-3099(12)70323-710.1016/S1473-3099(12)70323-7
]Search in Google Scholar
[
11. Lam SW, Bauer SR, Fowler R, Duggal A. Systematic Review and Meta-Analysis of Procalcitonin-Guidance Versus Usual Care for Antimicrobial Management in Critically Ill Patients: Focus on Subgroups Based on Antibiotic Initiation, Cessation, or Mixed Strategies. Crit Care Med. 2018 May;46(5):684-90. DOI: 10.1097/ CCM.000000000000295310.1097/CCM.0000000000002953
]Search in Google Scholar
[
12. Karaman S, Leppänen V-M, Alitalo K. Vascular endothelial growth factor signaling in development and disease. Development. 2018 Jul 20;145(14):dev151019. DOI: 10.1242/dev.15101910.1242/dev.151019
]Search in Google Scholar
[
13. Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem. 1994 Oct 14;269(41):25646-54. DOI: 10.1016/S0021-9258(18)47298-510.1016/S0021-9258(18)47298-5
]Search in Google Scholar
[
14. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 1997 Jul 1;16(13):3898-911. DOI: 10.1093/emboj/16.13.389810.1093/emboj/16.13.389811700149233800
]Search in Google Scholar
[
15. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9267-71. DOI: 10.1073/pnas.88.20.926710.1073/pnas.88.20.9267526951924389
]Search in Google Scholar
[
16. Azamfirei L, Gurzu S, Solomon R, Copotoiu R, Copotoiu S, Jung I, et al. Vascular endothelial growth factor: a possible mediator of endothelial activation in acute respiratory distress syndrome. Minerva Anestesiol. 2010 Aug;76(8):609-16.10.1378/chest.136.4_MeetingAbstracts.76S-a
]Search in Google Scholar
[
17. Astarita JL, Acton SE, Turley SJ. Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol. 2012;3:283. DOI: 10.3389/fimmu.2012.0028310.3389/fimmu.2012.00283343985422988448
]Search in Google Scholar
[
18. Wicki A, Christofori G. The potential role of podoplanin in tumour invasion. Br J Cancer. 2007 Jan 15;96(1):1-5. DOI: 10.1038/sj.bjc.660351810.1038/sj.bjc.6603518236021317179989
]Search in Google Scholar
[
19. Suzuki-Inoue K, Inoue O, Ozaki Y. Novel platelet activation receptor CLEC-2: from discovery to prospects. J Thromb Haemost. 2011 Jul;9 Suppl 1:44-55. DOI: 10.1111/j.1538-7836.2011.04335.x10.1111/j.1538-7836.2011.04335.x21781241
]Search in Google Scholar
[
20. Breiteneder-Geleff S, Matsui K, Soleiman A, Meraner P, Poczewski H, Kalt R, et al. Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol. 1997 Oct;151(4):1141-52.
]Search in Google Scholar
[
21. Maruyama Y, Maruyama K, Kato Y, Kajiya K, Moritoh S, Yamamoto K, et al. The effect of podoplanin inhibition on lymphangiogenesis under pathological conditions. Invest Ophthalmol Vis Sci. 2014 Jul 1;55(8):4813-22. DOI: 10.1167/iovs.13-1371110.1167/iovs.13-1371124985477
]Search in Google Scholar
[
22. Rayes J, Lax S, Wichaiyo S, Watson SK, Di Y, Lombard S, et al. The podoplanin-CLEC-2 axis inhibits inflammation in sepsis. Nat Commun. 2017 Dec 21;8(1):2239 DOI: 10.1038/s41467-017-02402-610.1038/s41467-017-02402-6574011129269852
]Search in Google Scholar
[
23. Kitano H, Kageyama S-I, Hewitt SM, Hayashi R, Doki Y, Ozaki Y, et al. Podoplanin expression in cancerous stroma induces lymphangiogenesis and predicts lymphatic spread and patient survival. Arch Pathol Lab Med. 2010 Oct;134(10):1520-7. DOI: 10.5858/2009-0114-OA.110.5858/2009-0114-OA.1755632320923309
]Search in Google Scholar
[
24. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. DOI: 10.1001/jama.2016.028710.1001/jama.2016.0287496857426903338
]Search in Google Scholar
[
25. Hahn RG. Endotoxin boosts the vascular endothelial growth factor (VEGF) in rabbits. J Endotoxin Res. 2003;9(2):97-100. DOI: 10.1177/0968051903009002040110.1177/09680519030090020401
]Search in Google Scholar
[
26. Adamik B, Zielinski S, Smiechowicz J, Kübler A. Endotoxin Elimination in Patients with Septic Shock: An Observation Study. Arch Immunol Ther Exp (Warsz). 2015 Dec;63(6):475-83. DOI: 10.1007/s00005-015-0348-810.1007/s00005-015-0348-8463344426093653
]Search in Google Scholar
[
27. Ramachandran G. Gram-positive and gram-negative bacterial toxins in sepsis: a brief review. Virulence. 2014 Jan 1;5(1):213-8. DOI: 10.4161/viru.2702410.4161/viru.27024391637724193365
]Search in Google Scholar
[
28. Bertani B, Ruiz N. Function and Biogenesis of Lipopolysaccharides. EcoSal Plus. 2018 Aug;8(1):10.1128/ ecosalplus.ESP-0001-2018. DOI: 10.1128/ecosalplus. ESP-0001-201810.1128/ecosalplus
]Search in Google Scholar
[
29. Matsuura M. Structural Modifications of Bacterial Lipopolysaccharide that Facilitate Gram-Negative Bacteria Evasion of Host Innate Immunity. Front Immunol. 2013;4:109. DOI: 10.3389/fimmu.2013.0010910.3389/fimmu.2013.00109366297323745121
]Search in Google Scholar
[
30. Poli-de-Figueiredo LF, Garrido AG, Nakagawa N, Sannomiya P. Experimental models of sepsis and their clinical relevance. Shock. 2008 Oct;30 Suppl 1:53-9. DOI: 10.1097/SHK.0b013e318181a34310.1097/SHK.0b013e318181a34318704008
]Search in Google Scholar
[
31. Zhu G, Huang Q, Huang Y, Zheng W, Hua J, Yang S, et al. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangio-genesis and lymphatic metastasis through the TLR4-NF-κB/JNK pathways in colorectal cancer. Oncotarget. 2016 Oct 4;7(45):73711-24. DOI: 10.18632/oncotarget.1244910.18632/oncotarget.12449534200927713159
]Search in Google Scholar
[
32. Zhang Y, Lu Y, Ma L, Cao X, Xiao J, Chen J, et al. Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-κB signaling and protects against endotoxin shock. Immunity. 2014 Apr 17;40(4):501-14. DOI: 10.1016/j.immuni.2014.01.01310.1016/j.immuni.2014.01.01324656836
]Search in Google Scholar
[
33. Pan P, Liu X, Wu L, Li X, Wang K, Wang X, et al. TREM-1 promoted apoptosis and inhibited autophagy in LPS-treated HK-2 cells through the NF-κB pathway. Int J Med Sci. 2021 Jan 1;18(1):8-17. DOI: 10.7150/ ijms.5089310.7150/ijms.50893773895433390769
]Search in Google Scholar
[
34. Foster RR, Satchell SC, Seckley J, Emmett MS, Joory K, Xing CY, et al. VEGF-C promotes survival in podocytes. Am J Physiol Renal Physiol. 2006 Jul;291(1):F196-207. DOI: 10.1152/ajprenal.00431.200510.1152/ajprenal.00431.200516525158
]Search in Google Scholar
[
35. Quintanilla M, Montero-Montero L, Renart J, Martín-Villar E. Podoplanin in Inflammation and Cancer. Int J Mol Sci. 2019 Feb 6;20(3):707. DOI: 10.3390/ ijms2003070710.3390/ijms20030707638683830736372
]Search in Google Scholar
[
36. Ugorski M, Dziegiel P, Suchanski J. Podoplanin - a small glycoprotein with many faces. Am J Cancer Res. 2016;6(2):370-86.
]Search in Google Scholar
[
37. Winde CM de, Makris S, Millward L, Benjamin AC, Cazzagon G, Martinez VG, et al. Podoplanin function is switched by partner proteins on fibroblastic reticular cells. BioRxiv. 2019 Nov (cited 2021 Sep 21):793141. DOI: 10.1101/79314110.1101/793141
]Search in Google Scholar
[
38. Hitchcock JR, Cook CN, Bobat S, Ross EA, Flores-Langarica A, Lowe KL, et al. Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets. J Clin Invest. 2015 Dec;125(12):4429-46. DOI: 10.1172/JCI7907010.1172/JCI79070466579226571395
]Search in Google Scholar
[
39. Kerrigan AM, Navarro-Nu-ez L, Pyz E, Finney BA, Willment JA, Watson SP, et al. Podoplanin-expressing inflammatory macrophages activate murine platelets via CLEC-2. J Thromb Haemost. 2012 Mar;10(3):484-6. DOI: 10.1111/j.1538-7836.2011.04614.x10.1111/j.1538-7836.2011.04614.x343365322212362
]Search in Google Scholar